Target intelligence / Profile preview

Actin-like protein AlpC (AlpC)

Target
AlpC
Molecular classification
Bacterial cytoskeleton protein, Actin-like protein (ALP) family, ATPase
01

Overview

AlpC is a bacterial actin-like protein primarily identified in species such as Bacillus subtilis and certain pathogenic bacteria, where it plays a critical role in the stable inheritance of low-copy-number plasmids. It functions by polymerizing into dynamic filaments that physically push or pull plasmid DNA to opposite poles of the cell during division, a process driven by ATP hydrolysis. Because AlpC is essential for the maintenance of plasmids that often carry virulence factors and antibiotic resistance genes, it is considered an emerging target for novel antimicrobial strategies. Disrupting AlpC polymerization or its interaction with adapter proteins like AlpR can lead to plasmid loss, thereby reducing bacterial pathogenicity and reversing drug resistance. While no clinical drugs currently target AlpC, its distinct structural differences from eukaryotic actin make it a viable candidate for selective inhibition.

Other names
Actin-like protein CAlp7AAlfA-like proteinBacterial actin homolog
02

Mechanism of action

Inhibition of filament polymerization or ATP-binding pocket disruption to prevent plasmid inheritance and bacterial fitness.

03

Biological functions

Plasmid segregationDNA bindingFilament formationATP hydrolysisCytoskeleton organization
04

Disease associations

Bacterial infectionAntimicrobial resistance (via plasmid maintenance)
05

Safety considerations

Potential for rapid resistance developmentSpecificity requirements to avoid cross-reactivity with eukaryotic actin
06

Biomarkers

Plasmid copy numberAlpC filament visualization (research context)

Beyond the preview

Go deeper on Actin-like protein AlpC (AlpC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin-like protein AlpC (AlpC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call